{
  "id": "nclex_ngn_mc_2026_011",
  "questionType": "multipleChoice",
  "stem": "The nurse is reviewing the client's electronic health record (EHR) and preparing to administer the scheduled 0900 (9:00 AM) medications. Based on the provided data, which action is the highest priority for the nurse to take?",
  "options": [
    {
      "label": "C",
      "content": "Request a neurology consult to evaluate the client's clonus and hyperreflexia."
    },
    {
      "label": "A",
      "content": "Withhold the scheduled dose of sertraline and notify the healthcare provider immediately."
    },
    {
      "label": "D",
      "content": "Administer the scheduled sertraline and document the client's mental status changes."
    },
    {
      "label": "B",
      "content": "Administer the PRN lorazepam for severe agitation and apply a cooling blanket."
    }
  ],
  "case": {
    "title": "54-year-old client with altered mental status",
    "tabs": [
      {
        "id": "tab1",
        "title": "Nurses' Note",
        "content": "0730 (07:30): Client admitted from home with acute onset of confusion and agitation. Partner reports client has a history of major depressive disorder and migraines. Partner states, \"They seemed more depressed lately and started taking St. John's Wort from the health food store about two weeks ago because they couldn't get a timely appointment with their psychiatrist.\" On assessment, client is diaphoretic, restless, and unable to follow complex commands. Spontaneous, inducible clonus noted in both ankles. Deep tendon reflexes are +4 in lower extremities. Pupils are mydriatic."
      },
      {
        "id": "tab2",
        "title": "Vital Signs",
        "content": {
          "type": "table",
          "headers": [
            "Time",
            "Temperature",
            "Heart Rate",
            "Blood Pressure",
            "Respiratory Rate",
            "SpO2"
          ],
          "rows": [
            [
              "0730 (07:30) (ED)",
              "38.8° C (101.8° F)",
              "128",
              "168/94",
              "24",
              "96% on room air"
            ],
            [
              "0800 (08:00)",
              "39.4° C (102.9° F)",
              "136",
              "172/98",
              "26",
              "95% on room air"
            ],
            [
              "0830 (08:30)",
              "40.1° C (104.2° F)",
              "142",
              "180/102",
              "28",
              "94% on room air"
            ]
          ]
        }
      },
      {
        "id": "tab3",
        "title": "Laboratory Results",
        "content": {
          "type": "table",
          "headers": [
            "Test",
            "Result",
            "Reference Range"
          ],
          "rows": [
            [
              "Sodium",
              "140 mEq/L",
              "135-145 mEq/L"
            ],
            [
              "Potassium",
              "4.1 mEq/L",
              "3.5-5.0 mEq/L"
            ],
            [
              "BUN",
              "22 mg/dL",
              "10-20 mg/dL"
            ],
            [
              "Creatinine",
              "1.3 mg/dL",
              "0.6-1.2 mg/dL"
            ],
            [
              "Creatine Kinase (CK)",
              "2,800 U/L",
              "30-200 U/L"
            ],
            [
              "Lactate, Venous",
              "3.1 mmol/L",
              "0.5-2.2 mmol/L"
            ]
          ]
        }
      },
      {
        "id": "tab4",
        "title": "Medication Administration Record (MAR)",
        "content": {
          "type": "table",
          "headers": [
            "Medication",
            "Dose",
            "Route",
            "Frequency",
            "Notes"
          ],
          "rows": [
            [
              "Sertraline",
              "100 mg",
              "PO",
              "Daily at 0900 (09:00)",
              "For major depressive disorder"
            ],
            [
              "Sumatriptan",
              "50 mg",
              "PO",
              "PRN for migraine",
              "Last dose yesterday evening"
            ],
            [
              "Lorazepam",
              "2 mg",
              "IV",
              "PRN every 4 hrs for severe agitation",
              "Available to give"
            ]
          ]
        }
      }
    ]
  },
  "rationale": {
    "correct": "The client's clinical presentation strongly suggests Serotonin Syndrome, a potentially life-threatening condition resulting from excessive serotonin activity in the central nervous system. The key findings include: altered mental status (confusion, agitation), autonomic hyperactivity (hyperthermia, tachycardia, hypertension, diaphoresis), and neuromuscular abnormalities (hyperreflexia, clonus). The client is taking sertraline (SSRI) and sumatriptan (triptan), both serotonergic agents, and recently started St. John's Wort, which also has serotonergic properties. The elevated CK and lactate levels indicate rhabdomyolysis and metabolic acidosis, serious complications of Serotonin Syndrome. The priority is to immediately stop the causative agent, sertraline, to prevent further serotonin accumulation and worsening of the condition. Administering sertraline would exacerbate the toxicity, potentially leading to seizures, multi-organ failure, and death. Notifying the provider is crucial for initiating further treatment.",
    "incorrect": "The incorrect options either fail to address the underlying cause of the life-threatening syndrome, are secondary in priority, or are actively harmful. This question assesses the ability to recognize a critical contraindication and take immediate action to prevent further harm.",
    "answerBreakdown": [
      {
        "label": "A",
        "content": "Withhold the scheduled dose of sertraline and notify the healthcare provider immediately.",
        "isCorrect": true,
        "justification": "This is the correct action. Recognizing the signs and symptoms of Serotonin Syndrome, the nurse must immediately withhold the sertraline to prevent further toxicity. Notifying the provider is essential for initiating further treatment, such as benzodiazepines for agitation/rigidity and potentially cyproheptadine as an antidote. This addresses the root cause and prevents further harm."
      },
      {
        "label": "B",
        "content": "Administer the PRN lorazepam for severe agitation and apply a cooling blanket.",
        "isCorrect": false,
        "justification": "While lorazepam and cooling measures are appropriate treatments for Serotonin Syndrome, they are secondary interventions. The absolute first priority is to stop the offending medication (sertraline). Treating the symptoms without addressing the underlying cause is insufficient and potentially dangerous. This does not address the root cause."
      },
      {
        "label": "C",
        "content": "Request a neurology consult to evaluate the client's clonus and hyperreflexia.",
        "isCorrect": false,
        "justification": "Requesting a neurology consult delays critical, life-saving intervention. While a neurologist might eventually be consulted, the signs and symptoms strongly suggest a medication-induced toxicity that requires immediate action by the nurse and primary provider. The situation is too acute for this delay. This delays treatment."
      },
      {
        "label": "D",
        "content": "Administer the scheduled sertraline and document the client's mental status changes.",
        "isCorrect": false,
        "justification": "This is the most dangerous option. Administering more of the causative agent (sertraline) would be catastrophic, accelerating the progression of Serotonin Syndrome towards severe hyperthermia, rhabdomyolysis, seizures, and cardiovascular collapse. This demonstrates a failure to recognize a life-threatening contraindication. This will worsen the condition."
      }
    ]
  },
  "pedagogy": {
    "bloomLevel": "Analyzing",
    "cjmmStep": "Take Actions",
    "nclexCategory": "Pharmacological and Parenteral Therapies",
    "nclexSubcategory": "Adverse Effects/Side Effects/Toxic Effects/Contraindications",
    "difficulty": "Level 5",
    "topicTags": [
      "Serotonin Syndrome",
      "Medication Safety",
      "Adverse Effects",
      "Contraindications",
      "Pharmacology",
      "Critical Thinking",
      "Health Equity",
      "Social Determinants of Health"
    ]
  },
  "clinicalPearls": [
    "Serotonin Syndrome is a potentially life-threatening condition caused by excessive serotonergic activity in the central nervous system, often triggered by combining multiple serotonergic medications or supplements.",
    "The classic triad of Serotonin Syndrome includes mental status changes, autonomic hyperactivity, and neuromuscular abnormalities. However, presentation can vary.",
    "Early recognition and immediate cessation of all serotonergic agents are crucial in managing Serotonin Syndrome. Supportive care and specific antidotes (e.g., cyproheptadine) may also be necessary.",
    "Always obtain a thorough medication history, including over-the-counter medications and herbal supplements, to identify potential drug interactions and risks for Serotonin Syndrome.",
    "Rhabdomyolysis, indicated by elevated CK levels, is a serious complication of Serotonin Syndrome and requires prompt intervention to prevent kidney damage. Monitor urine output and renal function.",
    "Consider Serotonin Syndrome in any patient presenting with altered mental status, autonomic instability, and neuromuscular abnormalities, especially if they are taking serotonergic medications."
  ],
  "sbar": {
    "situation": "A 54-year-old client with a history of major depressive disorder and migraines presents with acute onset of confusion, agitation, hyperthermia, tachycardia, hypertension, diaphoresis, hyperreflexia, and clonus.",
    "background": "The client's partner reports the client recently started taking St. John's Wort. The client is currently prescribed sertraline and takes sumatriptan PRN for migraines. Laboratory results show elevated CK (2,800 U/L) and lactate (3.1 mmol/L) levels.",
    "assessment": "The client is exhibiting signs and symptoms consistent with Serotonin Syndrome, likely due to the combination of sertraline, sumatriptan, and St. John's Wort. The elevated CK and lactate indicate possible rhabdomyolysis and metabolic acidosis.",
    "recommendation": "Immediately withhold the scheduled 0900 (09:00) dose of sertraline and notify the healthcare provider. Prepare for supportive care, including cooling measures, IV fluids, and potential administration of benzodiazepines or cyproheptadine. Monitor vital signs, mental status, and laboratory values closely, especially CK, creatinine, and urine output."
  },
  "sentinelStatus": "healed_v2026_v8"
}